POSB132 Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients with Acute Heart Failure with Reduced Ejection Fraction: Events Avoided and Cost Savings from the Perspective of Healthcare Payers in the United States
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.405
https://www.valueinhealthjournal.com/article/S1098-3015(21)02200-2/fulltext
Title :
POSB132 Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients with Acute Heart Failure with Reduced Ejection Fraction: Events Avoided and Cost Savings from the Perspective of Healthcare Payers in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02200-2&doi=10.1016/j.jval.2021.11.405
First page :
Section Title :
Open access? :
No
Section Order :
11181